Amniocentesis Needle Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 225.31 Mn

Forecast Year, 2035

USD 444.17 Mn

CAGR, 2026 - 2035

7.02%

Report Coverage

Global

What is the Amniocentesis Needle Market Size?

The global amniocentesis needle market size accounted for USD 225.31 million in 2025 and is predicted to increase from USD 241.30 million in 2026 to approximately USD 444.17 million by 2035, expanding at a CAGR of 7.02% from 2026 to 2035. The market growth is attributed to the increasing prevalence of high-risk pregnancies and advancements in prenatal genetic testing technologies.

Amniocentesis Needle Market Key Takeaways

• In terms of revenue, the market is valued at $225.31 million in 2025.
• It is projected to reach $444.17 million by 2035.
• The market is expected to grow at a CAGR of 7.02% from 2026 to 2035.
• North America held the major market share of 32% in 2025.
• Asia Pacific is expected to grow at a CAGR of 7.1% in the upcoming period (2026-2035).
• By type, the 100 to 150 mm segment contributed the biggest market share of 53% in 2025.
• By type, the smaller than 100 mm segment is expected to grow at the fastest rate between 2026 and 2035.
• By procedure, the amniocentesis procedures segment led the market in 2025.
• By procedure, the fetal blood transfusion segment is projected to grow at a significant CAGR during the assessment years.
• By end-use, the hospitals segment accounted for the biggest market share of 35% in 2025.
• By end-use, the clinics segment is projected to expand rapidly in the market in the coming years.

Market Overview

The worldwide amniocentesis needle market is witnessing significant growth due to the rising demand for reliable prenatal genetic testing. The rising number of cases of high-risk pregnancies, notably among women who are 35 and older, creates the need for early and accurate detection of chromosomal aberrations. This significantly boosts the demand for advanced prenatal screening options, in which amniocentesis needles play a crucial role. According to the MAYO CLINIC's report, around 100,000 women in the U.S. gave birth at the age of 40 in 2023. This further intensifies the need for amniocentesis to support reliable diagnoses.

Impact of Artificial Intelligence on the Amniocentesis Needle Market

Artificial intelligence increases the accuracy and safety of amniocentesis needle procedures. By utilizing AI-powered ultrasound, clinicians can see live needle placement, limiting the possibility of adverse outcomes in fetal sampling. Manufacturers can use AI technologies to design models that show needles' interactions with different anatomies. AI also helps in the development of next-generation needles. Furthermore, AI enhances the quality of amniocentesis needles.

Amniocentesis Needle Market Growth Factors

• Rising Adoption of Non-Invasive Prenatal Testing: The growing popularity of non-invasive prenatal tests (NIPT), which support early detection of genetic disorders, significantly increases the need for amniocentesis procedures.
• Advancements in Ultrasound Technology: Continuous improvements in ultrasound systems are anticipated to enhance the safety and accuracy of amniocentesis procedures, driving demand for precision needles.
• Increasing Healthcare Access in Developing Regions: Expanding healthcare infrastructure in emerging markets like India and China is likely to increase access to prenatal diagnostic services, including amniocentesis.
• Government Support for Prenatal Care: Policies aimed at improving maternal health, such as subsidized prenatal testing and genetic counseling programs, are projected to boost the adoption of amniocentesis procedures globally.
• Rising Maternal Age: The increasing trend of delayed pregnancies, especially among women over 35, is expected to drive demand for prenatal diagnostic tests like amniocentesis, as older mothers are at higher risk for genetic disorders.
• Enhancements in Needle Technology: Innovations such as improved needle coatings and ergonomic designs are expected to make amniocentesis procedures safer, leading to wider acceptance and growth in usage.
• Growing Focus on Personalized Medicine : The shift towards personalized healthcare, with an emphasis on genetic testing and tailored treatments, is likely to further drive the demand for amniocentesis as a diagnostic tool for genetic disorders.

Market Scope

Market Dynamics

Drivers

Rising Prevalence of Genetic Disorders

The increasing rates of genetic disorders are anticipated to boost the need for diagnostic procedures like amniocentesis, which drives the growth of the amniocentesis needle market. The healthcare sector is experiencing rapid surge in the number of cases of chromosomal abnormalities, such as Down syndrome, Edwards syndrome and neural tube defects. Medical specialists commonly recommend amniocentesis as a reliable procedure for diagnosis of these conditions in the second trimester. Early and accurate fetal examinations are becoming increasingly important. According to the U.S. Centers for Disease Control and Prevention's 2024 report, about one of 700 babies born in the U.S. develops a risk of Down Syndrome. This number is expected to rise in the coming years due to factors like hormonal changes, creating the need for amniocentesis procedures.

Restraint

Rising Preference for Non-Invasive Prenatal Testing

The rising preference for non-invasive prenatal testing (NIPT) is expected to hinder the growth of the amniocentesis needle market. Medical centers are beginning to prefer non-invasive prenatal testing (NIPT), which involves examination of the mother's blood for evidence of chromosomal abnormality. NIPT reduces the risks associated with amniocentesis. Healthcare professionals and consumers are becoming more aware of the benefits and availability of non-invasive procedures, encouraging them to shift toward NIPT. This significantly reduces the need for amniocentesis needles.

Opportunity

Increasing Global Healthcare Expenditure

Increasing global healthcare expenditure is projected to create immense opportunities for players competing in the amniocentesis needle market. Higher healthcare spending enables wider access to prenatal care, including amniocentesis procedures. Higher spending further contributes to research and development, leading to innovations in amniocentesis needles. The rising government initiatives to improve maternal care opens up new avenues for market growth by increasing the availability of prenatal tests.

• According to the World Health Organization (WHO), the total expenditure on healthcare globally was USD 8.3 trillion by 2024, of which a massive budget was spent on maternal and child health services.

Segment Insights

Type Insights

The 100 to 150 mm segment held the biggest market share of 53% in 2025. This is mainly due to their best balance between precision and user-friendliness. This is the optimal range for drawing amniotic fluid during the second-trimester amniocentesis, a procedure normally performed between 15 and 20 weeks of pregnancy. These needles ensure safe and effective insertion into the amniotic sac, minimizing the risk of injury to both fetus and mother. Moreover, these mid-length needles are applicable for vaccination and drug administration due to their versatility.

The smaller than 100 mm segment is expected to grow at the fastest rate in the upcoming period. The growth of the segment is attributed to the increasing demand for minimally invasive techniques. These needles reduce injury risks to the fetus due to their smaller size and less invasive nature. This further enhances the comfort of the patient. Furthermore, the increasing maternal and fetal safety concerns drive the growth of this segment.

Procedure Insights

The amniocentesis procedures segment accounted for the major market share in 2025. This is mainly due to their major role in detecting genetic disorders during the second stage of gestation. Clinicians take advantage of these procedures for the purpose of taking samples of amniotic fluid. Further, they are tested to identify chromosomal disorders, such as Down syndrome and Edwards syndrome. As per the report published by the United Nations, 1 in 1000 children are born with Down syndrome each year. Moreover, approximately 3,000 to 5,000 children are born with a chromosome disorder. Furthermore, age-related pregnancies are associated with an elevated rate of genetic disorders, leading to an increased use of amniocentesis.

The fetal blood transfusion segment is projected to grow at a significant CAGR during the assessment years. A fetal blood transfusion is normally done when the fetus is at risk of blood anemia, and care must be taken to ensure that there are no complications. Increasing rates of Rh incompatibility and other blood incompatibilities in pregnancy are expected to increase the demand for FBT. The World Health Organization (WHO) has recognized that fetal anemia is one of the most important factors increasing fetal morbidity and mortality in certain regions. Additionally, improvements in accessibility to healthcare services in developing regions are projected to drive the growth of the segment.

End-use Insights

The hospitals segment generated the biggest market share of 35% in 2025. Amniocentesis demand in hospitals is tremendous since these centers have adequate facilities to treat high-risk pregnancies, genetic disorders, and multiple complications. These settings come with modern ultrasound-guided equipment, which makes the amniocentesis procedures more accurate. The increased rates of high-risk pregnancies and the increased relevance of genetic testing imply that hospitals remain the primary providers of prenatal diagnosis.

The clinics segment is projected to expand rapidly in the market in the coming years, due to the convenience of access, quick service, and more affordable prices as compared to the hospital environment. More women are opting to undertake early prenatal screening and genetic screening privately in less congested environments. Clinics where specialized care and personalized service are preferred are likely to experience an increase in the number of these procedures undertaken amniocentesis procedures. Furthermore, improvements in diagnostic technology, rising popularity of elective prenatal testing, and frequency of amniocentesis procedures at clinics are expected to increase.

Regional Insights

What is the U.S. Amniocentesis Needle Market Size?

The U.S. amniocentesis needle market size was exhibited at USD 64.17 million in 2025 and is projected to be worth around USD 129.88 million by 2035, growing at a CAGR of 7.31% from 2026 to 2035.

North America led the amniocentesis needle market by capturing the largest share in 2025. This is mainly due to its advanced healthcare system and increased awareness among people about the importance of prenatal genetic screening. The U.S. held the maximum share with its increased investment in comprehensive diagnostic tools and the high incidence of high-risk pregnancies. Supportive regulatory frameworks for prenatal care and increased need for genetic testing boosted the demand for amniocentesis procedures. The CDC predicted that prenatal genetic screening (amniocentesis) will remain at the forefront of attention in 2024 as a result of expectant mothers' heightened awareness and advanced prenatal technologies. The increase in the number of high-risk pregnancies and the usage of non-invasive prenatal testing bolstered the growth of the market.

U.S. Amniocentesis Needle Market Trends

The U.S. market is expanding as more prenatal diagnostic procedures are performed to detect genetic abnormalities, driven by rising awareness and an increase in high-risk pregnancies among older mothers. Advanced healthcare infrastructure and widespread adoption of precision-guided and ultrasound-compatible needles in hospitals and clinics support steady demand.

Asia Pacific is anticipated to witness the fastest growth during the forecast period. The rising government initiatives to improve healthcare infrastructure, particularly in countries like China and India, are likely to boost the growth of the market. There is a strong emphasis on maternal care, boosting the demand for various diagnostic procedures, including amniocentesis. The rise in older maternal age and high-risk pregnancies is contributing to the demand for genetic screening tests. India plays a major role in the Asia Pacific amniocentesis needle market. The increasing number of cases of genetic diseases and the availability of advanced prenatal screening options are driving the growth of the market.

China Amniocentesis Needle Market Trends

China's market is growing as prenatal diagnostic procedures become more common with expanded healthcare access and rising awareness of genetic screening. Demand is supported by increasing numbers of high-risk pregnancies and broader maternal health programs across urban and rural regions.

What are the Advancements in the Amniocentesis Needle Market in Europe?

Europe is expected to witness notable growth, driven by increasing investment in healthcare and high demand for sophisticated prenatal testing. European countries such as Germany, France, and the UK have robust healthcare infrastructure, with the widespread availability of sophisticated diagnostic solutions. Additionally, the increasing number of cases of complicated pregnancies, especially among older women, is projected to raise the demand for amniocentesis in this region.

Germany Amniocentesis Needle Market Trends: The region benefits from stringent regulatory standards that ensure high-quality medical devices, thus fostering consumer acceptance and trust. Additionally, government initiatives aimed at improving maternal health are expected to further boost market growth. The rising prevalence of genetic disorders has also increased demand.

What are the Key Trends in the Amniocentesis Needle Industry in Latin America?

Latin America is expected to witness substantial growth in the market. This growth is driven by various factors such as increasing healthcare expenditure, rising awareness of prenatal diagnostics, and improving healthcare infrastructure. Additionally, government initiatives aimed at enhancing maternal health services are gaining traction, expected to further stimulate demand. Countries like Brazil and Mexico are leading players.

Brazil Amniocentesis Needle Market Trends

Key players in the region are introducing innovative products that are tailored to local needs. The market landscape is evolving steadily, with both multinational corporations and local firms competing for market share.

Rising awareness of fetal health, expanding healthcare infrastructure, and greater access to maternal care services are key factors boosting demand for amniocentesis needles. Additionally, improvements in medical technology and a focus on safer, more efficient needle designs are supporting adoption by obstetricians and prenatal specialists.

How is the Middle East and Africa Region Growing in the Amniocentesis Needle Industry?

The Middle East and Africa region is expected to grow at a steady pace in the upcoming years. This growth is driven by increasing awareness of prenatal care and the rising prevalence of genetic disorders. Various government initiatives aimed at improving maternal health are expected to open up new opportunities in this sector. Countries like South Africa and the UAE are leading players in the region.

Saudi Arabia Amniocentesis Needle Market Trends

The country's market landscape is characterized by a mix of local and international players, who are actively working to expand their presence. As healthcare systems evolve and improve, the region is likely to see a gradual increase in the adoption of amniocentesis needles.

Increasing awareness of prenatal diagnostics and rising numbers of procedures performed to detect genetic anomalies are key drivers of market growth. Additionally, innovations in needle design and safety, along with greater availability of prenatal care services, are enhancing adoption in hospitals and clinics across the country.

Supply Chain Analysis: Amniocentesis Needle Market

• Raw Material Sourcing
  This stage deals with sourcing raw materials, which are needed to produce amniocentesis needles, such as medical-grade stainless steel, plastics, and polymer components.
  Key Players: Alleima, DuPont, Covestro
• Manufacturing Process
  In this stage, the raw materials are used to produce precision medical needles. The process includes needle forming, sharpening, polishing, and assembling with other components.
  Key Players: Becton Dickinson, Cook Medical, Medtronic
• Distribution Process
  After the needles are manufactured, they are packaged under strictly controlled conditions and then distributed to hospitals, diagnostic centers, and maternity clinics.
  Key Players: Cardinal Health, McKesson, Henry Schein

Amniocentesis Needle Market Companies

• Smiths Medical: Smiths Medical is a global leader in the development of medical devices and solutions, specializing in a wide range of healthcare products, including amniocentesis needles. The company is renowned for its commitment to innovation and quality, consistently introducing advanced products that enhance patient care and safety.
• Biopsybell Srl:Biopsybell Srl is a prominent player in the medical technology sector, known for its high-quality biopsy and amniocentesis needles. The company specializes in developing innovative solutions that cater to the needs of healthcare professionals and patients alike. Biopsybell's amniocentesis needles are designed with precision and safety in mind, ensuring optimal performance during procedures.
• Integra LifeSciences: Integra LifeSciences is a leading global medical technology company that develops innovative solutions for various surgical and medical needs, including amniocentesis needles. The company is dedicated to improving patient outcomes through advanced technology and high-quality products.

Other Major Key Players

• Becton Dickinson and Company
• Cook Medical
• CooperSurgical
• Laboratoire CCD
• Medline
• RI.MOS. Srl
• Rocket Medical

Segments Covered in the Report

By Type

• 100 to 150 mm
• Larger Than 150 mm
• Smaller Than 100 mm

By Procedure

• Amniocentesis Procedures
• Amnioinfusion Procedures
• Amnioreduction Procedures
• Cordocentesis Procedures
• Fetal Blood Transfusion

By End-use

• Clinics
• Diagnostics Centers
• Hospitals
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa